Inventor · disambiguated record
John Latham
Also filed as: LATHAM JOHN · LATHAM JOHN A
124 granted patents·37 pending applications·2,796 citations·filing 1994–2024
99Inventor score
Files withALDERBIO HOLDINGS LLC71H LUNDBECK AS18ALDER BIOPHARMACEUTICALS INC12UCB PHARMA SA8GARCIA-MARTINEZ LEON7
Top patents by PatentIndex Score
161 records- 0198US10533048B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Jan 14, 2020·11 cites·30 claims
- 0298US8337847B2Methods of treating anemia using anti-IL-6 antibodiesSMITH JEFFREY T L·Filed 2009·Granted Dec 25, 2012·48 cites·35 claims
- 0398US7935340B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2008·Granted May 3, 2011·111 cites·28 claims
- 0498US7906117B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2008·Granted Mar 15, 2011·55 cites·23 claims
- 0597US11938185B2Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Mar 26, 2024·3 cites·42 claims
- 0697US10066009B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2016·Granted Sep 4, 2018·19 cites·30 claims
- 0797US8323649B2Antibodies to IL-6 and use thereofGARCIA-MARTINEZ LEON·Filed 2009·Granted Dec 4, 2012·56 cites·28 claims
- 0897US8178101B2Use of anti-IL-6 antibodies having specific binding properties to treat cachexiaGARCIA-MARTINEZ LEON·Filed 2009·Granted May 15, 2012·48 cites·16 claims
- 0997US8062864B2Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodiesGARCIA-MARTINEZ LEON·Filed 2009·Granted Nov 22, 2011·52 cites·55 claims
- 1097US7927863B2Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategyALDER BIOPHARMACEUTICALS INC·Filed 2006·Granted Apr 19, 2011·38 cites·28 claims
- 1197US7872106B2Sclerostin-binding antibodiesAMGEN INC·Filed 2008·Granted Jan 18, 2011·86 cites·25 claims
- 1297US7578999B2Antibodies specific for sclerostinCELLTECH R & D INC·Filed 2006·Granted Aug 25, 2009·66 cites·23 claims
- 1397US7381409B2Antibodies specific for sclerostin and methods of screening and use thereforCELLTECH R & D INC·Filed 2004·Granted Jun 3, 2008·68 cites·16 claims
- 1496US10179809B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Jan 15, 2019·13 cites·30 claims
- 1596US9884912B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2014·Granted Feb 6, 2018·15 cites·13 claims
- 1696US9255154B2Anti-PCSK9 antibodies and use thereofALDERBIO HOLDINGS LLC·Filed 2013·Granted Feb 9, 2016·36 cites·20 claims
- 1796US9085615B2Antibodies to IL-6 to inhibit or treat inflammationALDERBIO HOLDINGS LLC·Filed 2012·Granted Jul 21, 2015·29 cites·32 claims
- 1896US7868134B2Immunogenic peptides derived from sclerostinUCB MFG INC·Filed 2008·Granted Jan 11, 2011·49 cites·20 claims
- 1996US7592429B2Sclerostin-binding antibodyUCB SA·Filed 2006·Granted Sep 22, 2009·166 cites·5 claims
- 2096US5582981AMethod for identifying an oligonucleotide aptamer specific for a targetGILEAD SCIENCES INC·Filed 1994·Granted Dec 10, 1996·483 cites·12 claims
- 2195US12162936B2Methods of treatment with anti-PACAP antibodiesH LUNDBECK AS·Filed 2021·Granted Dec 10, 2024·2 cites·23 claims
- 2295US11993648B2Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversionH LUNDBECK AS·Filed 2020·Granted May 28, 2024·3 cites·9 claims
- 2395US10975135B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Apr 13, 2021·4 cites·34 claims
- 2495US10968268B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Apr 6, 2021·4 cites·34 claims
- 2595US10954285B2Humanized anti-PACAP antibodiesH LUNDBECK AS·Filed 2020·Granted Mar 23, 2021·4 cites·34 claims
- 2695US10266587B2Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferersALDERBIO HOLDINGS LLC·Filed 2017·Granted Apr 23, 2019·12 cites·4 claims
- 2795US10214582B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Feb 26, 2019·12 cites·30 claims
- 2895US10208112B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Feb 19, 2019·12 cites·30 claims
- 2995US10189895B2Anti-CGRP compositions and use thereofALDERBIO HOLDINGS LLC·Filed 2018·Granted Jan 29, 2019·12 cites·29 claims
- 3095US9481725B2Antibodies to HGF and compositions containingALDERBIO HOLDINGS LLC·Filed 2014·Granted Nov 1, 2016·16 cites·11 claims
- 3195US9452227B2Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragmentsGARCIA-MARTINEZ LEON·Filed 2009·Granted Sep 27, 2016·27 cites·21 claims
- 3295US8268582B2Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategyCREGG JAMES M·Filed 2004·Granted Sep 18, 2012·51 cites·31 claims
- 3395US5756291AAptamers specific for biomolecules and methods of makingGILEAD SCIENCES INC·Filed 1995·Granted May 26, 1998·441 cites·12 claims
- 3494US10100108B2Antibodies to HGF and compositions containingALDERBIO HOLDINGS LLC·Filed 2016·Granted Oct 16, 2018·6 cites·20 claims
- 3594US9834603B2Antibodies to IL-6 and use thereofALDERBIO HOLDINGS LLC·Filed 2015·Granted Dec 5, 2017·7 cites·11 claims
- 3694US9011856B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2012·Granted Apr 21, 2015·7 cites·30 claims
- 3794US8992911B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2012·Granted Mar 31, 2015·7 cites·17 claims
- 3894US8911734B2Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75LATHAM JOHN A·Filed 2011·Granted Dec 16, 2014·40 cites·45 claims
- 3994US8728473B2Methods of preventing or treating pain using anti-NGF antibodiesGARCIA-MARTINEZ LEON F·Filed 2011·Granted May 20, 2014·27 cites·52 claims
- 4093US10053506B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2015·Granted Aug 21, 2018·9 cites·14 claims
- 4193US9821057B2Anti-IL-6 antibody for use in the treatment of cachexiaALDERBIO HOLDINGS LLC·Filed 2015·Granted Nov 21, 2017·9 cites·1 claims
- 4293US9724410B2Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicitySMITH JEFFREY T L·Filed 2010·Granted Aug 8, 2017·13 cites·25 claims
- 4393US9725509B2Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibodyALDERBIO HOLDINGS LLC·Filed 2015·Granted Aug 8, 2017·9 cites·34 claims
- 4493US9187560B2Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or feverALDERBIO HOLDINGS LLC·Filed 2012·Granted Nov 17, 2015·8 cites·19 claims
- 4592US10640560B2Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or feverALDERBIO HOLDINGS LLC·Filed 2018·Granted May 5, 2020·3 cites·12 claims
- 4692US10533045B2Antibody purification and purity monitoringALDERBIO HOLDINGS LLC·Filed 2016·Granted Jan 14, 2020·12 cites·13 claims
- 4792US10202435B2Anti-PACAP antibodies and uses thereofALDER BIOPHARMACEUTICALS INC·Filed 2017·Granted Feb 12, 2019·9 cites·19 claims
- 4892US9783603B2Therapeutic use of antibodies to HGFALDERBIO HOLDINGS LLC·Filed 2015·Granted Oct 10, 2017·5 cites·14 claims
- 4992US9745373B2Anti-CGRP compositions and use thereofKOVACEVICH BRIAN ROBERT·Filed 2012·Granted Aug 29, 2017·21 cites·40 claims
- 5092US9518082B2Antibody purification and purity monitoringALDERBIO HOLDINGS LLC·Filed 2014·Granted Dec 13, 2016·16 cites·11 claims
Showing the top 50 of 161 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Latham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →